Replies to post #2235 on Medical Cannabis Payment Solutions (REFG)

[JFXL2]

"Searching, Don;t misunderstand me. I'm not happy with their silence either. Per the OTC Markets Web site: I hope Jeremy Roberts knows this out there.

REFG STOP SIGN posted. Never good when trying to attract new investors
Medical Cannabis Payment Solutions

Common Stock 0.026655 -0.00234 -8.09%

0.0261 / 0.0298 (1 x 1)

Real-Time Best Bid & Ask: 01:28pm 04/05/2019
Delayed (15 Min) Trade Data: 01:33pm 04/05/2019
Overview, Quote, , company Profile, Security Details, News, Financials
Disclosure, Research

Warning! This company may not be making material information publicly available

Buying or selling this security on the basis of material nonpublic material information is prohibited under Section 10(b) of the Securities Exchange Act of 1934 and Rules 10b-5 and 10b5-1 thereunder. Violators may be subject to civil and criminal penalties.

OPEN
0.03

DAILY RANGE
0.0261 - 0.03

VOLUME
456,982

DIVIDEND
N/A

[I-Man]

Hey searching, right now ARYC has already gone down that road and like 4 years behind on reporting, and SEC does nothing. An over 20 year bio-medical company, with major positioning in that market too. Because under SEC rules, for an OTC, there is no definitive date of which to report, and that company's CEO keeps building hope, yet stretches out docs and filings, and essentially, as long as they are on OTC, they can get away with it.

Why they need to uplist to legitimate exchange and go from there.

No trust on OTC no matter how good your company and products are as is case right now with ARYC...